Recent Media Coverage

After Advanz’s £100m fine over the price of its thyroid tablets, two people recount the difficulty of obtaining medication.

One that recently hit the market — winning Food and Drug Administration approval in June — is Novo Nordisk’s Wegovy, a higher-dose version of the company’s injectable diabetes drug, Ozempic.

Rep. Scott Peters once backed Democrats' price-control bill. Now critics say he's a "paid mercenary" for Big Pharma.

An estimated 50 million inpatient surgical procedures occur each year in the United States, at a cost of $175 billion.

The Competition and Markets Authority (CMA) said the fine “sends a clear message” to the pharmaceutical industry that breaking the law will not be tolerated.

Competition watchdog found company’s ‘excessive and unfair’ prices cost NHS almost £30m extra over 10 years.

The only consistent aspect of drug pricing in the United States is that the breadth of its variations and fluctuations are inexplicable to the consumer.

Private equity firms Cinven and Hg have been fined by the U.K.’s competition watchdog after a pharmaceutical firm they once owned was found to have overcharged for crucial drugs.

Nearly two months after the Alzheimer's drug Aduhelm received conditional approval from the Food and Drug Administration, experts are still debating how, and whether, it should be used.

Prescriptions for Sanofi’s Lantus can now be swapped with biosimilar product Semglee.

Pfizer expects an adjusted pretax profit in the high 20% range of revenue for the vaccine.

The United States has in recent weeks donated millions of vaccine doses to countries such as Bangladesh, Bhutan and South Korea.